Work

Selective histone deacetylase inhibition augments melanoma immunotherapy.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.e14521

Authors: Andressa Sodre Laino, David Michael Woods, Amod Sarnaik, Steven Quayle3, Simon S. Jones3, Eduardo M. Sotomayor, Jeffrey S. Weber

Institutions: NYU Langone Health, New York University, Moffitt Cancer Center, Acetylon Pharmaceuticals (United States)

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2889564529

Cites:

Cited by: 1

Related to: 10